Healthcare industry reported 85 deals worth $30 billion in Feb 2021
Three big ticket deals contribute 74 per cent of total deal value in Feb 2021
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Oxford study indicates AstraZeneca’s COVID-19 vaccine woks against Brazil variant: Report
The exact efficacy of the vaccine against the variant is not known
Kite gets US FDA nod for Yescarta to treat relapsed or refractory follicular lymphoma
Yescarta is the first CAR T-Cell therapy approved for indolent follicular lymphoma
Encourage members to adopt IPDMS: NPPA to pharma associations
The authority has also requested pharma associations to provide information regarding member companies that have already…
Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform
Interim data from clinical trials show PulmoHeal’s efficacy in improving recovery of mild and moderate Covid-19 patients
Sun Pharma to acquire stake in WRS Bioproducts, Australia
WRS Bioproducts develops novel technologies to produce supplements and nutraceutical ingredients from diverse algae species
Amgen to buy Five Prime Therapeutics in $1.9 million deal
Through the latest deal, Amgen will get access to Five Prime’s lead drug candidate, bemarituzumab, which is ready to enter a…
Shilpa Medicare gets US FDA tentative nod for Apremilast Tablets
The tablets are used in the treatment of 'psoriatic arthritis'
Aptamer Group, AstraZeneca extend collaboration to explore next-gen drug delivery approaches
The companies will evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of…
SII writes letter to PMO recommending reforms in drug regulatory system
The letter requests that the provision for manufacturing and stockpiling of COVID-19 vaccine under clinical trial for marketing…